EUVIMEDEUVIMED entdecken
Crossref

IgA is the predominant isotype of anti- β 2 glycoprotein I in patients with COVID-19

Sarra Melayah iD, Nouha Omrani, Hela Alouini, Mariam Ghozzi iD, Sawssen Mrad, Mohamed Boussarsar, Houda Chaouch, Wissem Hachfi, Amel Letaief, Amani Mankaï iD, Ibtissem Ghedira

Laboratory Medicine · 2024

DOI: 10.1093/labmed/lmad097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laboratory Medicine, 2024. Verfasst von Sarra Melayah und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunology, Farhat Hached University Hospital, Sousse, Tunisia. Hauptthemen laut MEDLINE: COVID-19, Immunoglobulin A, beta 2-Glycoprotein I, SARS-CoV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The aim of this research was to determine the frequency of antiphospholipid antibodies (aPL) in patients with COVID-19.

Methods

The frequency and titers of anticardiolipin antibodies (aCL) and anti-β2 glycoprotein I antibodies (aβ2GPI) were determined in sera of adult patients hospitalized with COVID-19. Immunoglobulin (Ig)G, IgA, IgM aCL, and aβ2GPI were measured using enzyme-linked immunosorbent assay.

Results

Eighty-three patients were included in the study. The mean age of patients was 62 ± 13.9 years, ranging from 23 to 86 years. Stratification according to severity of infection divided patients in 2 groups: 45 patients with moderate infection and 38 patients with critical or severe infection. Out of the 83 patients suffering from COVID-19, aPL (aCL or aβ2GPI) were detected in 24 patients (28.9%). IgG, IgA and IgM aβ2GPI were positive in 2.4%, 16.9% and 8.4%, respectively. IgG, IgA and IgM aCL showed positivity in 7.2%, 0%, and 4.8%, respectively. The frequency of aPL was 36.8% in patients with critical/severe infection and 22.2% in patients with moderate infection. In critical/severe patients, the frequency of aβ2GPI was significantly higher than aCL (34.2% vs 13.2%, P = .03) and aβ2GPI-IgA were significantly more frequent than aβ2GPI-IgG (21.1% vs 2.6%, P = .028).

Conclusion

In this cross-sectional study, aPL and particularly aβ2GPI-IgA were common in patients with COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Immunoglobulin Abeta 2-Glycoprotein ISARS-CoV-2HumansMiddle AgedMaleFemaleAdultAgedAged, 80 and overYoung AdultAntibodies, AntiphospholipidAntibodies, AnticardiolipinImmunoglobulin MEnzyme-Linked Immunosorbent Assay

Stichwörter der Autor:innen

COVID-19adultsanti-β2 glycoprotein I antibodiesanticardiolipin antibodiesantiphospholipid antibodiesautoimmunity

Substanzen

Immunoglobulin Abeta 2-Glycoprotein IAntibodies, AntiphospholipidAntibodies, AnticardiolipinImmunoglobulin M

Autor:innen und Institutionen

  • Laboratory of Immunology, Farhat Hached University Hospital, Sousse, Tunisia.
  • Department of Immunology, Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.
  • LR12SP11, Department of Biochemistry, Sahloul University Hospital, Sousse, Tunisia.
  • Faculty of Sciences of Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • LR14SP02, Research Unit "Epidemiology and Immunogenetics of Viral Infections," Sahloul University Hospital, Sousse, Tunisia.
  • Laboratory of Biochemistry, Farhat Hached University Hospital, Sousse, Tunisia.

ORCID-Profile: Sarra Melayah, Mariam Ghozzi, Amani Mankaï

Zitieren

APA

Melayah, S., Omrani, N., Alouini, H., Ghozzi, M., Mrad, S., Boussarsar, M., Chaouch, H., Hachfi, W., Letaief, A., Mankaï, A., & Ghedira, I. (2024). IgA is the predominant isotype of anti- β 2 glycoprotein I in patients with COVID-19. Laboratory Medicine. https://doi.org/10.1093/labmed/lmad097

Vancouver

Melayah S, Omrani N, Alouini H, Ghozzi M, Mrad S, Boussarsar M, et al. IgA is the predominant isotype of anti- β 2 glycoprotein I in patients with COVID-19. Laboratory Medicine. 2024. doi:10.1093/labmed/lmad097

BibTeX
@article{Melayah2024,
  author = {Melayah, Sarra and Omrani, Nouha and Alouini, Hela and Ghozzi, Mariam and Mrad, Sawssen and Boussarsar, Mohamed and Chaouch, Houda and Hachfi, Wissem and Letaief, Amel and Mankaï, Amani and Ghedira, Ibtissem},
  title = {IgA is the predominant isotype of anti- β 2 glycoprotein I in patients with COVID-19},
  journal = {Laboratory Medicine},
  year = {2024},
  doi = {10.1093/labmed/lmad097}
}
Kostenlos starten →